Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Chronic Obstructive Pulmonary Disease”

308 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 308 results

Testing effectiveness (Phase 2)Study completedNCT00634413
What this trial is testing

Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Pulmagen Therapeutics 91
Testing effectiveness (Phase 2)Study completedNCT04039113
What this trial is testing

Tezepelumab COPD Exacerbation Study

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 337
Testing effectiveness (Phase 2)Study completedNCT01108913
What this trial is testing

Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Revotar Biopharmaceuticals AG 60
Large-scale testing (Phase 3)Study completedNCT01574651
What this trial is testing

The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 934
Not applicableLooking for participantsNCT07382258
What this trial is testing

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novlead Inc. 16
Testing effectiveness (Phase 2)Study completedNCT03276078
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
AstraZeneca 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07330310
What this trial is testing

Trial of JKN2401 Injection in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Joincare Pharmaceutical Group Industry Co., Ltd 888
Testing effectiveness (Phase 2)Study completedNCT03645434
What this trial is testing

A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 73
Large-scale testing (Phase 3)Study completedNCT01462929
What this trial is testing

Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 414
Post-approval studies (Phase 4)Study completedNCT01966107
What this trial is testing

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.

Who this might be right for
COPDChronic Obstructive Pulmonary DiseaseModerate to Very Severe COPD
AstraZeneca 3,635
Testing effectiveness (Phase 2)Study completedNCT03706209
What this trial is testing

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
MetrioPharm AG 155
Post-approval studies (Phase 4)Study completedNCT00115492
What this trial is testing

Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 797
Testing effectiveness (Phase 2)Looking for participantsNCT07082738
What this trial is testing

Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 1,160
Post-approval studies (Phase 4)Study completedNCT02153489
What this trial is testing

A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 30
Early research (Phase 1)Study completedNCT04647383
What this trial is testing

Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Sleep Apnea, ObstructivePulmonary Disease, Chronic ObstructiveRespiration Disorders
Eisai Inc. 63
Post-approval studies (Phase 4)Study completedNCT01656005
What this trial is testing

Beta Blocker Therapy in Moderate to Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of Dundee 18
Large-scale testing (Phase 3)Study completedNCT01490125
What this trial is testing

The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 247
Testing effectiveness (Phase 2)Study completedNCT01426009
What this trial is testing

Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sunovion Respiratory Development Inc. 140
Testing effectiveness (Phase 2)Study completedNCT01233232
What this trial is testing

A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Scientific Terminology Chronic Obstructive Pulmonary Disease (COPD)Laymen Terminology Chronic Bronchitis and Emphysema
AstraZeneca 109
Large-scale testing (Phase 3)Study completedNCT01294787
What this trial is testing

Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
COPD
Novartis Pharmaceuticals 85
Load More Results